Career Development

职业发展

基本信息

项目摘要

CAREER DEVELOPMENT COMPONENT OF THE UCLA-ICMIC. F.I. The UCLA-ICMIC Career Development Component has been, and will continue to be, a flexible program. Our goal is to train outstanding candidates who have an interest in the interdisciplinary interface of basic cancer research and/or clinical-translational studies with molecular imaging applications. At the end of their ICMIC support, we hope their training will contribute to careers that increase cancer discovery research or improve diagnosis, prediction of response to therapy and/or monitoring of therapy. We are as flexible as possible with regard to the spectrum of trainees that we will recruit and support. However, we make - as a condition of support from Career Development resources - a provision that recipients participate in didactic instruction either in Cancer Biology or in principles of Biological Imaging (or both!) if the review committee is of the opinion that the candidate has a deficiency that will not be corrected by laboratory participation alone. Our Internal Review Board, made up of our Research Component P.l.s (Drs. Hong Wu, Caius Radu, Antoni Ribas), Drs. Herschman and Phelps, and Drs. Owen Witte and Jonathan Braun review applications and select trainees. We will also require, as a condition of support, that individual trainees participate in portions (tailored to the individual) of a "curriculum" that includes specific courses, individual laboratory research group meetings, participation in Crump Institute for Molecular Imaging, Jonsson Comprehensive Cancer Center and Institute of Molecular Medicine internal seminars, and UCLA-ICMIC weekly research meetings. We will also request of trainees and their mentors that trainees receive some practical experience in all the imaging modalities available in our Specialized Resources. Our goal, in addition to a successful research project, will be that - at the conclusion of their support period - the trainees will be familiar with the fundamental principles of biological imaging and cancer biology, and expert in one or more areas of imaging and cancer research. While we will not expect trainees to have mastered radiosynthetic chemistry, mathematical reconstructions of tomographic images and all the other technologies required for their research in this interdisciplinary program, we will expect a working knowledge of all these areas and expertise in their areas of concentration.
UCLA-ICMIC的职业发展组成部分。 F.I. UCLA-ICMIC职业发展组成部分已经并且将继续是灵活的 程序。我们的目标是培训对基本癌症研究和/或通过分子成像应用的跨学科界面感兴趣的杰出候选人。在其ICMIC支持结束时,我们希望他们的培训将有助于增加癌症发现研究或改善诊断,预测对治疗的反应和/或治疗治疗的职业。对于我们将招募和支持的学员,我们尽可能灵活。但是,我们将作为职业发展资源的支持条件 - 一项规定,如果审查委员会认为候选人的缺陷将不会仅通过实验室参与来纠正,则接受者参与癌症生物学或生物成像(或两者兼而有之)的教学教学。我们的内部审查委员会由我们的研究组件P.L.S(Hong Wu博士,Caius Radu,Antoni Ribas)组成,Drs。赫斯曼和菲尔普斯,博士。欧文·维特(Owen Witte)和乔纳森·布劳恩(Jonathan Braun)审查申请和精选学员。作为支持的条件,我们还将要求单个学员参与“课程”的部分(量身定制),其中包括特定课程,个别实验室研究小组会议,参与Crump Molecular Imaging Institute for Crump Institute of Jonsson综合癌症中心和分子医学研究所内部研讨会和UCLA-ICMIC-ICMIC Week研究会议。我们还将要求受训者及其导师 学员在我们的专业资源中可用的所有成像方式中获得了一些实践经验。除了成功的研究项目外,我们的目标是 - 在他们的支持期结束时 - 学员将熟悉生物成像和癌症生物学的基本原理,以及在一个或多个成像和癌症研究领域的专家。尽管我们不会期望受训者能够掌握放射合成化学,层析成像图像的数学重建以及在此跨学科计划中所需的所有其他技术,但我们期望在集中注意力领域中对所有这些领域的工作知识和专业知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Harvey R. Herschman其他文献

Neurochemical properties of cell lines from<em>N</em>-ethyl-<em>N</em>-nitrosourea induced rat tumors
  • DOI:
    10.1016/0006-8993(77)90288-8
  • 发表时间:
    1977-07-15
  • 期刊:
  • 影响因子:
  • 作者:
    Gregory J. West;Jiro Uki;Roland Stahn;Harvey R. Herschman
  • 通讯作者:
    Harvey R. Herschman
Identification and characterization of a brain-specific antigen enriched in neonatal brain. I. Developmental, regional distribution and molecular weight studies
  • DOI:
    10.1016/0006-8993(78)90952-6
  • 发表时间:
    1978-07-28
  • 期刊:
  • 影响因子:
  • 作者:
    Donna D. Strong;Harvey R. Herschman
  • 通讯作者:
    Harvey R. Herschman
Regulation of the rat metallothionein-I gene by sodium butyrate.
丁酸钠对大鼠金属硫蛋白-I 基因的调节。
  • DOI:
    10.1093/nar/14.2.853
  • 发表时间:
    1986
  • 期刊:
  • 影响因子:
    14.9
  • 作者:
    Bruce W. Birren;Harvey R. Herschman
  • 通讯作者:
    Harvey R. Herschman
Identification and characterization of a brain-specific antigen enriched in neonatal brain. II. Antigenic stability, species cross-reactivity and tumor cell association
  • DOI:
    10.1016/0006-8993(80)90798-2
  • 发表时间:
    1980-02-24
  • 期刊:
  • 影响因子:
  • 作者:
    Donna D. Strong;Harvey R. Herschman
  • 通讯作者:
    Harvey R. Herschman
Seizure activity induces PIM‐1 expression in brain
癫痫发作活动诱导大脑中 PIM-1 表达
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    J. Feldman;L. Vician;Marianna Crispino;G. Tocco;M. Baudry;Harvey R. Herschman
  • 通讯作者:
    Harvey R. Herschman

Harvey R. Herschman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Harvey R. Herschman', 18)}}的其他基金

Organization and Administration
组织与管理
  • 批准号:
    7991414
  • 财政年份:
    2010
  • 资助金额:
    $ 9.64万
  • 项目类别:
Developmental Funds
发展基金
  • 批准号:
    7991463
  • 财政年份:
    2010
  • 资助金额:
    $ 9.64万
  • 项目类别:
Transductionally Redirected and Transcriptionally Restricted Adenovirus Therapy..
转导重定向和转录限制腺病毒疗法..
  • 批准号:
    7991423
  • 财政年份:
    2010
  • 资助金额:
    $ 9.64万
  • 项目类别:
Small Animal Imaging Shared Resource
小动物成像共享资源
  • 批准号:
    7944612
  • 财政年份:
    2009
  • 资助金额:
    $ 9.64万
  • 项目类别:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
表皮、成纤维细胞和内皮细胞COX-2在皮肤癌中的作用
  • 批准号:
    7804210
  • 财政年份:
    2009
  • 资助金额:
    $ 9.64万
  • 项目类别:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
表皮、成纤维细胞和内皮细胞COX-2在皮肤癌中的作用
  • 批准号:
    8105087
  • 财政年份:
    2007
  • 资助金额:
    $ 9.64万
  • 项目类别:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
表皮、成纤维细胞和内皮细胞COX-2在皮肤癌中的作用
  • 批准号:
    7633349
  • 财政年份:
    2007
  • 资助金额:
    $ 9.64万
  • 项目类别:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
表皮、成纤维细胞和内皮细胞COX-2在皮肤癌中的作用
  • 批准号:
    7458647
  • 财政年份:
    2007
  • 资助金额:
    $ 9.64万
  • 项目类别:
Career Development Program
职业发展计划
  • 批准号:
    7315101
  • 财政年份:
    2007
  • 资助金额:
    $ 9.64万
  • 项目类别:
The role of epidermal, fibroblast and endothelial cell COX-2 in skin cancer
表皮、成纤维细胞和内皮细胞COX-2在皮肤癌中的作用
  • 批准号:
    7845543
  • 财政年份:
    2007
  • 资助金额:
    $ 9.64万
  • 项目类别:

相似海外基金

University of Wisconsin Prostate SPORE
威斯康星大学前列腺孢子
  • 批准号:
    10555398
  • 财政年份:
    2023
  • 资助金额:
    $ 9.64万
  • 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
  • 批准号:
    10606212
  • 财政年份:
    2023
  • 资助金额:
    $ 9.64万
  • 项目类别:
Transcription and Replication of Oncogenic Viruses in Hypoxia
缺氧条件下致癌病毒的转录和复制
  • 批准号:
    10714172
  • 财政年份:
    2023
  • 资助金额:
    $ 9.64万
  • 项目类别:
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
胆管癌会议:分子驱动因素、微环境和精准医学
  • 批准号:
    10747566
  • 财政年份:
    2023
  • 资助金额:
    $ 9.64万
  • 项目类别:
Research Core
研究核心
  • 批准号:
    10557581
  • 财政年份:
    2023
  • 资助金额:
    $ 9.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了